英文名稱 | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
---|---|
中文名稱 | 瑪格妥昔單抗 |
CAS號(hào) | 1350624-75-7 |
儲(chǔ)存條件 | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3600.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥15500.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥28500.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥126000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥235000.00 | 登錄后可見(jiàn) |
英文名稱 | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
---|---|
中文名稱 | 瑪格妥昔單抗 |
CAS號(hào) | 1350624-75-7 |
儲(chǔ)存條件 | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.